QUIA.ST

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
QUIA.STQuia Pharma AB (publ)	$0.00	-16.67%	$1M	—
APTA.STAptahem AB (publ)	$0.35	-8.38%	$9M	—
CMH.STChordate Medical Holding AB (publ)	$0.10	-37.50%	$269962	—
FLUI.STFluicell AB (publ)	$32.80	-0.00%	$45M	—
GABA.STGabather AB (publ)	$0.03	+2.92%	$7M	—
LIDDS.STLIDDS AB (publ)	$0.02	+0.00%	$3M	—
PLUN.STProstaLund AB (publ)	$0.21	-35.15%	$775547	—

Source: Financial Modeling Prep · peers by sector/industry

Quia Pharma AB (publ)

Quia Pharma AB specializes in the research, development, and commercialization of advanced drug delivery systems. Its core product, Uni-Qleaver®, utilizes a pioneering releasable pegylation technology. This innovative approach effectively mitigates common drawbacks and allows for the precise modulation of a drug's half-life. The company, established by Marek Kwiatkowski, is headquartered in Uppsala, Sweden.

www.quiapeg.com

Employees: 3
IPO / List date: Jun 21, 2005
HQ: SE

Held by traders on TradeandTell

No one on the platform currently holds QUIA.ST.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in QUIA.ST as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded QUIA.ST yet.